HES and Acute Kidney Injury in Adult Cardiac Surgery
- Conditions
- Acute Kidney Injury After Adult Cardiac Surgery
- Interventions
- Drug: Crystalloid
- Registration Number
- NCT02445820
- Lead Sponsor
- University of Liege
- Brief Summary
This study retrospectively assess the effect or using balanced hydroxyethyl sctarch (HES) 130/0.4 or a balanced crystalloid solution as a pump prime and for intraoperative fluid therapy on the risk of early acute postoperative kidney injury in adult cardiac surgery patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 697
- Age ≥ 18 yo
- Having on pump cardiac surgery at CHU of Liège between April 2013 and June 2014
- Off pump surgery
- Use of Blood or Albumin in the cardiopulmonary bypass priming solution
- Preoperative dialysis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Crystalloid Crystalloid Balanced Crystalloid used as a pump prime and for intraoperative fluid therapy. HES HES Balanced HES 130/0.4 used as and pump prime and for intraoperative fluid therapy.
- Primary Outcome Measures
Name Time Method AKIN SCr Forty eight hours Stage of acute kidney injury using the Acute Kidney Injury Network Classification omitting the diuresis criteria.
- Secondary Outcome Measures
Name Time Method ICU stay 30 days Length of stay at the intensive care unit
Hospital stay 30 days Length of stay at the hospital
30-day mortality 30 days Death in hospital or within 30 days of surgery
AKIN SCr+UO Forty eight hours Stage of acute kidney injury using the Acute Kidney Injury Network Classification including the diuresis criteria.
Postoperative dialysis 30 days Requirement of postoperative renal replacement therapy
Respiratory complication 30 days Need for reintubation, non-invasive ventilation or prolonged intensive care unit stay as a consequence of atelectasis, pulmonary edema or pneumonia.